Checchi Capital Advisers’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.66M Sell
16,953
-395
-2% -$59.2K 0.12% 117
2026
Q1
$2.65M Sell
17,348
-409
-2% -$62.7K 0.13% 111
2025
Q4
$2.45M Sell
17,757
-119
-0.7% -$15.6K 0.13% 109
2025
Q3
$2.29M Buy
17,876
+401
+2% +$48.9K 0.12% 114
2025
Q2
$2.11M Sell
17,475
-740
-4% -$83.4K 0.12% 119
2025
Q1
$2.03M Buy
18,215
+903
+5% +$96.1K 0.11% 130
2024
Q4
$1.68M Sell
17,312
-250
-1% -$26.7K 0.1% 133
2024
Q3
$2.02M Sell
17,562
-616
-3% -$69.9K 0.11% 120
2024
Q2
$1.94M Sell
18,178
-210
-1% -$21.1K 0.1% 116
2024
Q1
$1.78M Sell
18,388
-168
-0.9% -$17.2K 0.14% 127
2023
Q4
$1.87M Buy
18,556
+158
+0.9% +$15.3K 0.15% 113
2023
Q3
$1.87M Buy
18,398
+413
+2% +$41.9K 0.17% 104
2023
Q2
$1.81M Buy
17,985
+683
+4% +$68.3K 0.16% 107
2023
Q1
$1.59M Sell
17,302
-249
-1% -$21.7K 0.15% 118
2022
Q4
$1.59M Sell
17,551
-136
-0.8% -$11.5K 0.17% 116
2022
Q3
$1.34M Buy
17,687
+11
+0.1% +$912 0.13% 125
2022
Q2
$1.52M Buy
17,676
+1,910
+12% +$168K 0.13% 121
2022
Q1
$1.38M Buy
15,766
+132
+0.8% +$11.4K 0.12% 123
2021
Q4
$1.37M Sell
15,634
-79
-0.5% -$6.56K 0.12% 126
2021
Q3
$1.28M Buy
15,713
+186
+1% +$16.7K 0.13% 121
2021
Q2
$1.42M Sell
15,527
-1,132
-7% -$101K 0.14% 122
2021
Q1
$1.42M Buy
16,659
+83
+0.5% +$7.45K 0.14% 115
2020
Q4
$1.56M Sell
16,576
-776
-4% -$67.8K 0.16% 107
2020
Q3
$1.51M Buy
17,352
+940
+6% +$81.4K 0.17% 90
2020
Q2
$1.43M Buy
16,412
+336
+2% +$29K 0.17% 88
2020
Q1
$1.32M Buy
16,076
+1,361
+9% +$121K 0.13% 83
2019
Q4
$1.39M Sell
14,715
-2,018
-12% -$181K 0.19% 89
2019
Q3
$1.45M Sell
16,733
-360
-2% -$32.3K 0.19% 75
2019
Q2
$1.56M Sell
17,093
-2,373
-12% -$201K 0.2% 76
2019
Q1
$1.68M Buy
19,466
+1,746
+10% +$140K 0.2% 71
2018
Q4
$1.36M Sell
17,720
-2,836
-14% -$221K 0.18% 77
2018
Q3
$1.59M Sell
20,556
-1,848
-8% -$137K 0.18% 77
2018
Q2
$1.52M Buy
22,404
+4,002
+22% +$276K 0.19% 73
2018
Q1
$1.33M Buy
18,402
+389
+2% +$29.6K 0.18% 82
2017
Q4
$1.35M Buy
18,013
+78
+0.4% +$5.88K 0.18% 79
2017
Q3
$1.38M Sell
17,935
-3,095
-15% -$234K 0.14% 75
2017
Q2
$1.57M Buy
21,030
+3,847
+22% +$273K 0.17% 67
2017
Q1
$1.14M Buy
17,183
+2,408
+16% +$160K 0.13% 84
2016
Q4
$964K Sell
14,775
-1,921
-12% -$125K 0.13% 91
2016
Q3
$1.18M Sell
16,696
-3,193
-16% -$233K 0.13% 79
2016
Q2
$1.47M Buy
19,889
+1,052
+6% +$72.7K 0.17% 65
2016
Q1
$1.22M Buy
18,837
+1,116
+6% +$75.9K 0.27% 73
2015
Q4
$1.37M Sell
17,721
-2,018
-10% -$160K 0.34% 56
2015
Q3
$1.63M Buy
19,739
+2,445
+14% +$218K 0.44% 47
2015
Q2
$1.52M Buy
17,294
+1,974
+13% +$181K 0.4% 56
2015
Q1
$1.35M Buy
15,320
+1,898
+14% +$168K 0.4% 58
2014
Q4
$1.11M Buy
13,422
+858
+7% +$71.1K 0.42% 58
2014
Q3
$1.06M Buy
12,564
+1,302
+12% +$105K 0.44% 52
2014
Q2
$914K Buy
11,262
+2,240
+25% +$176K 0.42% 54
2014
Q1
$687K Sell
9,022
-39
-0.4% -$2.84K 0.42% 56
2013
Q4
$653K Buy
+9,061
New +$630K 0.51% 36

Other funds holding NVS

Checchi Capital Advisers's NVS Position: Q2 2026 in Review

Checchi Capital Advisers reduced its Novartis (NVS) stake by 2.3% in Q2 2026, selling an estimated $59.2K and leaving 16,953 shares worth $2.66M. The position accounts for 0.12% of the portfolio, ranked #117.

Checchi Capital Advisers first reported a position in NVS in Q4 2013 and has held it in 51 quarters since. 1,027 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Checchi Capital Advisers held 16,953 shares of Novartis worth $2.66M as of Q2 2026.
  • Checchi Capital Advisers sold 395 Novartis shares in Q2 2026, an estimated $59.2K.
  • Novartis made up 0.12% of Checchi Capital Advisers's portfolio in Q2 2026, its #117 holding.
  • Checchi Capital Advisers first reported a position in Novartis in Q4 2013 and has held it in 51 quarters since.
  • 1,027 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Checchi Capital Advisers's 13F filing for Q2 2026, filed 4 Aug 2026.